| Serial Number | 88893369 |
| Word Mark | TRINSERRA |
| Filing Date | Wednesday, April 29, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, November 28, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 31, 2021 |
| Goods and Services | house mark for a full line of biologic, biosimilar, and pharmaceutical preparations; house mark for a full line of biologics; house mark for a full line of biosimilars; house mark for a full line of pharmaceuticals; house mark for a full line of biologic, biosimilar, and pharmaceutical products; biologic, biosimilar, and pharmaceutical preparations for the treatment of bone disease; biologic, biosimilar, and pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith; biologic, biosimilar, and pharmaceutical preparations for the treatment of diabetes; biologic, biosimilar, and pharmaceutical preparations for treatment and prevention of autoimmune diseases and autoimmune disorders; biologic, biosimilar, and pharmaceutical oncology preparations; anti-inflammatories; biologic, biosimilar, and pharmaceutical preparations for the treatment of immune system related diseases and disorders; biologic, biosimilar, and pharmaceutical preparations for use in dermatology; biologic, biosimilar, and pharmaceutical preparations for use in rheumatology; biologic, biosimilar, and pharmaceutical preparations, namely, anti-interleukin-6 (IL-6) receptor monoclonal antibody for the treatment of disease caused by IL-6 production; biologic, biosimilar, and pharmaceutical preparations, namely, biopharmaceuticals based on human monoclonal antibodies for the treatment of immune and inflammatory diseases and disorders |
| Goods and Services | providing medical information; providing health information |
| Goods and Services | research and development of biologics, biosimilars, and pharmaceuticals; providing information in the field of scientific and medical research related to biologics, biosimilars, and pharmaceuticals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 12, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 12, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 12, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Xentria, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Chicago, IL 60631 |
| Party Name | Xentria, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Chicago, IL 60631 |
| Event Date | Event Description |
| Monday, November 28, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, November 28, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, April 22, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, April 20, 2022 | SOU EXTENSION 1 GRANTED |
| Wednesday, April 20, 2022 | SOU EXTENSION 1 FILED |
| Wednesday, April 20, 2022 | TEAS EXTENSION RECEIVED |
| Tuesday, October 26, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 31, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 31, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 11, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 27, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, July 26, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 26, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 26, 2021 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, January 29, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, January 29, 2021 | FINAL REFUSAL E-MAILED |
| Friday, January 29, 2021 | FINAL REFUSAL WRITTEN |
| Saturday, January 23, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, January 22, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 22, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, July 23, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, July 23, 2020 | NON-FINAL ACTION E-MAILED |
| Thursday, July 23, 2020 | NON-FINAL ACTION WRITTEN |
| Thursday, July 23, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, May 12, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, May 2, 2020 | NEW APPLICATION ENTERED IN TRAM |